BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 26887456)

  • 1. Put innovation science at the heart of discovery.
    Kusiak A
    Nature; 2016 Feb; 530(7590):255. PubMed ID: 26887456
    [No Abstract]   [Full Text] [Related]  

  • 2. A 'rule of 3' to revive Greek science, research and innovation.
    Kollias G; Lambris JD
    Nat Immunol; 2015 Dec; 16(12):1206-8. PubMed ID: 26580499
    [No Abstract]   [Full Text] [Related]  

  • 3. Policy: Boost basic research in China.
    Yang W
    Nature; 2016 Jun; 534(7608):467-9. PubMed ID: 27337328
    [No Abstract]   [Full Text] [Related]  

  • 4. China: Building an innovator.
    Phillips N
    Nature; 2016 May; 533(7601):S32-3. PubMed ID: 27144607
    [No Abstract]   [Full Text] [Related]  

  • 5. Market watch: a framework for biomedical innovation in emerging markets.
    Gautam A; Yang S
    Nat Rev Drug Discov; 2014 Sep; 13(9):646-7. PubMed ID: 25176427
    [No Abstract]   [Full Text] [Related]  

  • 6. Who will bankroll the next big idea?
    Kappas DJ
    Sci Am; 2013 Oct; 309(4):58-61. PubMed ID: 24137856
    [No Abstract]   [Full Text] [Related]  

  • 7. Kill the myth of the miracle machine.
    Sarewitz D
    Nature; 2017 Jul; 547(7662):139. PubMed ID: 28703203
    [No Abstract]   [Full Text] [Related]  

  • 8. How private-sector research is changing China.
    Murphy F
    Nature; 2018 Jan; 553(7688):S28-S30. PubMed ID: 29345661
    [No Abstract]   [Full Text] [Related]  

  • 9. China: Change tack to boost basic research.
    Didham RK; Zhu CD
    Nature; 2016 Aug; 536(7614):30. PubMed ID: 27488792
    [No Abstract]   [Full Text] [Related]  

  • 10. China: Standardize R&D costing.
    Sun Y; Cao C
    Nature; 2016 Aug; 536(7614):30. PubMed ID: 27488790
    [No Abstract]   [Full Text] [Related]  

  • 11. A Longitude Prize for the twenty-first century.
    Rees M
    Nature; 2014 May; 509(7501):401. PubMed ID: 24848027
    [No Abstract]   [Full Text] [Related]  

  • 12. Discovery and innovation: the (atomic) clock is ticking.
    Ellenbogen PH
    J Am Coll Radiol; 2012 Aug; 9(8):527-8. PubMed ID: 22863453
    [No Abstract]   [Full Text] [Related]  

  • 13. To the G20: incentivising antibacterial research and development.
    Årdal C; Baraldi E; Ciabuschi F; Outterson K; Rex JH; Piddock LJV; Findlay D;
    Lancet Infect Dis; 2017 Aug; 17(8):799-801. PubMed ID: 28689703
    [No Abstract]   [Full Text] [Related]  

  • 14. Why China needs your scientific expertise.
    Hruby D
    Nature; 2018 Jan; 553(7688):S2-S3. PubMed ID: 29345669
    [No Abstract]   [Full Text] [Related]  

  • 15. Obstacles and opportunities in Chinese pharmaceutical innovation.
    Ni J; Zhao J; Ung CO; Hu Y; Hu H; Wang Y
    Global Health; 2017 Mar; 13(1):21. PubMed ID: 28340579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The radical openness of science and innovation: Why uncertainty is inherent in the openness towards the future.
    Nowotny H
    EMBO Rep; 2015 Dec; 16(12):1601-4. PubMed ID: 26553939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The performance of China's biomedical innovation: a scientometric analysis.
    Tang X; Du J
    Sci China Life Sci; 2016 Oct; 59(10):1074-1082. PubMed ID: 27437700
    [No Abstract]   [Full Text] [Related]  

  • 18. Don't feed the trolls.
    Nature; 2014 Jun; 510(7503):7. PubMed ID: 24910865
    [No Abstract]   [Full Text] [Related]  

  • 19. On Singularities and Black Holes in Combination-Driven Models of Technological Innovation Networks.
    Solé R; Amor DR; Valverde S
    PLoS One; 2016; 11(1):e0146180. PubMed ID: 26821277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Germany's attitude to start-up firms is undergoing profound change.
    Curry A
    Nature; 2019 Mar; 567(7749):S64-S65. PubMed ID: 30918388
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.